Back to overview

Arseus: Publication of Guarantor List and Compliance Certificate

News 2 min read

Waregem (Belgium) / Rotterdam (the Netherlands)[1], 30 April 2013 – Arseus announces today that two companies have acceded as “Guarantor” in accordance with the Guarantee Declaration dated 12 June 2012 regarding the € 225,000,000 4.75% Bond with maturity date 2 July 2017:

  • Steunpunt Apotheek Mierlo-Hout B.V., a private limited liability company, validly incorporated under the laws of the Netherlands, registered under registration number 17083775 with the Chamber of Commerce.
  • Pharma-Cosmetic K.M. Adamowicz sp. z.o.o. with its statutory seat at Krakow, Poland.

The list of Guarantors has been updated in accordance with Article 10.4 of the Guarantee Declaration and is available at www.arseus.com.

In accordance with Condition 10 (b) of the Bonds a new Compliance Certificate is published. This Compliance Certificate is available at www.arseus.com.


In the event of any discrepancy between the English translation and the original Dutch version of this press release, the latter shall prevail.


For more information:
Constantijn van Rietschoten
Director of Corporate Communications
+31 88 33 11 222 (Office)
+31 6 53 69 15 85 (Mobile)
constantijn.van.rietschoten@arseus.com


Arseus profile
Arseus is a multinational group of companies that supplies products, services and concepts to professionals and institutions in the healthcare sector in 30 countries worldwide. Arseus is subdivided into four divisions and operates in the markets for pharmaceutical compounding for pharmacies, dental products, medical and surgical products, and medical ICT-solutions. The Belgian company Arseus NV is located in Waregem, and is listed on NYSE Euronext Brussels and NYSE Euronext Amsterdam. The operational activities of the Arseus group are driven by the Dutch company Arseus BV. The head office of Arseus BV is located in Rotterdam.

[1] This press release was sent out by Arseus NV and Arseus BV.

Please open the link below for the full press release: